Safe use and reliable supply of medical radionuclides

Last updated: 16.7.2025
Grant

This Euratom Research and Innovation Action aims to enhance the safe use and reliable supply of medical radionuclides, critical for the rapidly evolving field of therapeutic nuclear medicine and theranostics in oncology. It addresses key challenges in radionuclide production, supply chain resilience, and clinical application, fostering innovation and ensuring patient access to advanced cancer treatments.

Who is Funded: Eligible Applicants and Program Objectives

This section outlines the eligibility criteria for applicants, the geographical scope of the program, and its primary objectives. The program targets consortia focused on advancing medical radionuclide research and supply across Euratom Member States, with a strategic goal to ensure robust and safe access to these vital medical resources.

What is Funded: Project Scope and Eligible Activities

This section details the types of projects, thematic areas, and activities eligible for funding, focusing on critical aspects of medical radionuclide development and application. It also covers the permitted cost categories and the developmental stages of projects supported.

Type and Scope of Funding: Financial Parameters

This section outlines the financial details of the funding, including the type of instrument, the maximum available funding per project, and associated financial terms.

Conditions and Requirements for Applicants

This section details the essential rules, administrative, and legal conditions that applicants and beneficiaries must adhere to throughout the application and project implementation phases. It covers application formatting, consortium structure, and financial limitations.

Application Procedure: From Submission to Award

This section provides an overview of the application process, from submission to the evaluation and award channels. It details when the call closed and when applicants were informed of the evaluation results.

This section identifies the foundational legal and official documents that govern the Euratom Research and Training Programme and this specific funding opportunity, ensuring transparency and providing a framework for its operation.

Similar Programs

#medical radionuclides#Euratom funding#radioisotope supply#cancer treatment#nuclear medicine#radiopharmaceuticals#nuclear research#radiation protection#theranostics#innovative production#clinical trials#healthcare#nuclear technologies#EU funding#research and innovation#medical isotopes

Funding Overview

Funding Status

Funding Status:

Closed

Maximum Amount

Maximum Amount:

4,000,000 €

Allocated Budget

Allocated Budget:

4,000,000 €

Award Channel

Award Channel:

Framework Programme Call

Region

Region:

European Union Member States. International cooperation is encouraged, with a focus on developing radionuclide therapy capacities and resilience for Euratom Member States. Entities established in Ukraine and the United Kingdom are treated as entities established in an Associated Country.

Sectors

Sectors:

Healthcare, Medical Technology, Research and Development

Application Type

Application Type:

Consortium Required

Funding Stages

Funding Stages:

Applied Research, Experimental Development, Prototyping, Pilot Testing, Product Development

Funding Provider

Program Level:

European Union

Funding Body:

European Commission (Euratom Research and Training Programme)

Additional Partners:

Joint Research Centre (JRC)

0 x 0
XS